Display options
Share it on

Arch Virol. 1991;118(3):235-45. doi: 10.1007/BF01314033.

Transmission of human T-cell leukemia virus type I from a patient with HTLV-I associated myelopathy/tropical spastic paraparesis and an asymptomatic carrier to rabbits.

Archives of virology

H Minagawa, C A Mora, D M Asher, G A Stone, P P Liberski, C J Gibbs

Affiliations

  1. Laboratory of Central Nervous System Studies, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.

PMID: 1712582 DOI: 10.1007/BF01314033

Abstract

Rabbits were infected successfully with two strains of human T-cell leukemia virus type I (HTLV-I), one isolated from a Colombian patient with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and the other from an asymptomatic carrier. HTLV-I was repeatedly demonstrated in peripheral blood mononuclear cells (PBMNC) of infected rabbits, and the rabbits had elevated antibodies against the various structural proteins of HTLV-I. Four rabbits inoculated with HTLV-I-infected autologous lymphoid cells intravenously (i.v.) and intracerebrally (i.c.) had virus present in their PBMNC for more than 40 weeks, while those that were inoculated either with HTLV-I-infected human lymphoid cells or with autologous rabbit lymphoid cells intraperitoneally (i.p.) had episodes during which virus was not recovered from their PBMNC. The one rabbit inoculated i.p. developed antibodies to viral envelope glycoproteins earlier than did those inoculated i.v. and i.c. Rabbit lymphoid cell lines persistently infected with HTLV-I were established by cocultivating the rabbit PBMNC with HTLV-I-infected human lymphoid cells that had been irradiated or by inoculation with cell-free supernatant fluids of HTLV-I infected non-irradiated lymphoid cell cultures. HTLV-I-infected rabbit cell lines were of T-cell origin and expressed HTLV-I antigens by immunofluorescence. Electron microscopy revealed type-C retrovirus particles.

Similar articles

Show all 14 similar articles

References

  1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  2. Int J Cancer. 1988 Jun 15;41(6):868-72 - PubMed
  3. Jpn J Cancer Res. 1985 Dec;76(12):1147-53 - PubMed
  4. Lancet. 1987 May 9;1(8541):1085-6 - PubMed
  5. Int J Cancer. 1985 Jan 15;35(1):81-5 - PubMed
  6. Lancet. 1984 Jun 23;1(8391):1415-6 - PubMed
  7. Int J Cancer. 1986 May 15;37(5):775-9 - PubMed
  8. Ann Neurol. 1988;23 Suppl:S185-7 - PubMed
  9. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9 - PubMed
  10. Gan. 1983 Feb;74(1):1-4 - PubMed
  11. J Virol. 1990 Mar;64(3):1278-82 - PubMed
  12. Ann Neurol. 1988;23 Suppl:S143-50 - PubMed
  13. Lancet. 1986 May 3;1(8488):1031-2 - PubMed
  14. Lancet. 1985 Nov 30;2(8466):1247-8 - PubMed
  15. Int J Cancer. 1987 Sep 15;40(3):403-7 - PubMed
  16. Biochim Biophys Acta. 1980 May 30;607(3):445-56 - PubMed
  17. Int J Cancer. 1990 Jan 15;45(1):127-30 - PubMed
  18. J Infect Dis. 1989 Sep;160(3):371-9 - PubMed
  19. Jpn J Cancer Res. 1988 Mar;79(3):335-41 - PubMed
  20. Leuk Res. 1989;13(5):399-406 - PubMed
  21. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476-80 - PubMed
  22. J Exp Med. 1984 Apr 1;159(4):1105-16 - PubMed
  23. Ann Neurol. 1988;23 Suppl:S201-6 - PubMed
  24. Science. 1983 Dec 9;222(4628):1125-7 - PubMed
  25. Lancet. 1985 Aug 24;2(8452):407-10 - PubMed
  26. Lancet. 1982 May 1;1(8279):1016 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources